Broad Effectiveness: Study With Aripiprazole - Tabular View

Tracking Information
First Received Date ^ICMJE	May 8, 2002
Last Updated Date	June 27, 2008
Start Date ^ICMJE	July 2002
Primary Completion Date
Current Primary Outcome Measures ^ICMJE (submitted: September 9, 2005)	Safety Assessments
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	Complete list of historical versions of study NCT00036361 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE (submitted: September 9, 2005)	Safety Assessments
Original Secondary Outcome Measures ^ICMJE	Same as current

Descriptive Information
Brief Title ^ICMJE	Broad Effectiveness: Study With Aripiprazole
Official Title ^ICMJE	Broad Effectiveness: Study With Aripiprazole
Brief Summary	The purpose of this study is to learn if aripiprazole is effective in the treatment of a large number of persons diagnosed with schizophrenia or schizoaffective disorders
Detailed Description
Study Phase	Phase III
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Safety Study
Condition ^ICMJE	Schizophrenia Schizoaffective Disorder
Intervention ^ICMJE	Drug: Aripiprazole
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	444
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	- Patients with Schizophrenia or Schizoaffective Disorder
Gender	Both
Ages	18 Years to 75 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States

Administrative Information
NCT ID ^ICMJE	NCT00036361
Responsible Party
Study ID Numbers ^ICMJE	CN138-087
Study Sponsor ^ICMJE	Bristol-Myers Squibb
Collaborators ^ICMJE	Otsuka America Pharmaceutical
Investigators ^ICMJE
Information Provided By	Bristol-Myers Squibb
Verification Date	September 2007
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP